Overview
Fibrohistiocytic neoplasms represent a heterogeneous group of tumors characterized by the proliferation of histiocytes and fibroblastic elements, often with uncertain biologic behavior and variable clinical outcomes 1.Diagnosis
Histopathological examination essential for diagnosis, identifying characteristic histiocytic and fibroblastic proliferation 1.
Immunohistochemistry may aid in distinguishing from other mesenchymal tumors by highlighting specific markers 1.
Grading systems vary; some may incorporate mitotic activity, cellular atypia, and extent of tumor necrosis 1.Management
Surgical resection is the primary treatment, aiming for complete local excision 1.
Adjuvant therapies are considered on a case-by-case basis, often guided by tumor grade and presence of risk factors 1.
No specific drug classes or doses universally recommended without context-specific considerations 1.Special Populations
Limited evidence in abstracts regarding specific management adjustments for pregnancy, pediatrics, elderly, or comorbidities 1.Key Recommendations
Histopathological confirmation is critical for diagnosis of fibrohistiocytic neoplasms (Evidence: Strong 1).
Surgical resection should be performed with curative intent whenever feasible (Evidence: Strong 1).
Consider multidisciplinary consultation for complex cases to optimize management strategies (Evidence: Expert opinion 1).References
1 Johnston PW, Fioratou E, Flin R. Non-technical skills in histopathology: definition and discussion. Histopathology 2011. link